🇺🇸

US SEC Filing Intelligence

· daily

Federal IT & Cybersecurity Contracts — October 22, 2026

Three federal IT and cybersecurity contracts totaling $66,862,598 in obligations were reviewed, all civilian (0 of 3 defense-related), spread across HHS/CMS, DHS/USCIS, and HHS/NIH. The dominant theme is civilian health and immigration-related IT services, awarded primarily through small business set-asides and time-and-materials vehicles. All three signals are rated neutral (average strength 3.0/10, materiality 2-3/10), reflecting modest individual scale and no publicly traded parent identified for any recipient. The highest-materiality award is KYC Advisors LLC's $22,511,725 USCIS DevSecOps order (materiality 3/10), though it is early in performance with only $6,590,471 (about 29%) outlayed. The key watch item is option exercise across all three contracts, since each shows only 27-33% of its potential ceiling currently obligated, meaning most long-term value is contingent on future government action.

3 total filings
· daily

NASA & Space Contracts Intelligence — October 22, 2026

This digest covers a single NASA & Space contract record totaling $54,049,346 in obligations, with zero defense-related awards and a civilian-only split. The dominant theme is NASA's continued funding of JPL-managed space science R&D, represented by a cost-plus-fixed-fee delivery order from NASA Management Office -- JPL to California Institute of Technology for the Great Observatory Maturation Program (GOMAP). The highest-conviction read is that the award's pricing structure lowers performer risk and the government bears most overrun exposure, but the recipient is a nonprofit university, so the contract carries no direct public-market investment relevance. The key watch item is the roughly $64.8M of the $118,850,566 base-plus-options ceiling that remains unobligated, which depends on future option exercise and incremental funding through the 2028-03-26 end date. With only one record and signal strength of 2.0/10, this digest provides limited actionable equity signal.

1 total filings
· daily

All HHS Contracts — October 22, 2026

Three HHS contracts totaling $88,878,005 in obligations were recorded for the October 22, 2026 period, all civilian with zero defense-related awards. The award set is dominated by NIH and CMS services spending: WGL Energy Services ($44,527,131, NIH energy-related delivery order), Healthcare Management Solutions ($23,072,715, CMS small-business IT/professional services), and DynaNet Corporation ($21,278,158, NIH IT program support). All three carry neutral signals (average strength 3.0/10), so there is no high-conviction directional call from this batch. The strongest signal is the DynaNet and Healthcare Management Solutions IT services pair, which supports a durable NIH/CMS IT-services demand thesis, but it rests on unexercised options. The principal watch item is the gap between obligations and ceilings: DynaNet has only $4,134,410 outlayed against $21,278,158 obligated and a $64,887,919 ceiling, and the WGL award's scope is unclear from its own codes and description.

3 total filings
· daily

All DOE Contracts — October 22, 2026

This digest covers a single Department of Energy contract record with a $41,772,736 current obligation, all civilian-classified (0 of 1 defense-related) and sourced from the NNSA. The sole award is to The Aerospace Corporation, a nonprofit federally funded research center in El Segundo, CA, under a $146,156,020 base-plus-options ceiling, with $26,579,293 outlayed to date. The dominant theme is continued federal funding for nuclear security and nonproliferation analysis, though one contract cannot establish a multi-year budget trend. The highest-conviction signal is the neutral reading that the award confirms ongoing NNSA analytical spending but offers no direct public-equity exposure, since the recipient is tax-exempt. The key watch item is option exercise and incremental obligation activity against the remaining ceiling, which will determine whether the funded work continues on schedule through the 2027-05-31 current end date.

1 total filings
· daily

High-Value Federal Grants ($5M+) — October 22, 2026

These 13 high-value federal awards total $384,742,601 in obligations, but only one (The Aerospace Corporation's NNSA work, though that recipient is a nonprofit FFRDC) touches defense-adjacent categories, and the remaining twelve are civilian (NASA, HHS, USDA, Smithsonian, GSA, VA, DHS, DOT). Civilian spending dominates with no clear agency-wide budget trend derivable from single awards, and most recipients are private or nonprofit entities with no identified public-market parent. The highest-materiality items are the NASA/JPL GOMAP delivery order ($54,049,346 obligated, nonprofit recipient) and the Aerospace Corporation NNSA order ($41,772,736 obligated), neither of which offers direct equity exposure. The dominant signal is that the publicly investable exposure in this batch is thin: WGL Energy Services (via AltaGas Limited, $44,527,131) is the only award with an identifiable listed parent, and its scope is unclear. The key watch item is the $401,685,093 base-plus-options ceiling on the DHS/FPS protective security award to Universal Protection Service, where only $22,644,780 is currently obligated and nothing has been outlayed.

13 total filings
· daily

DOE Energy Grants — October 22, 2026

This digest covers a single federal award totaling $41,772,736 in current obligation, issued under the DOE Energy Grants stream to The Aerospace Corporation, a nonprofit federally funded research center in El Segundo, CA. The award is a civilian (DOE NNSA) delivery order, so the defense/civilian split is 0 defense and 1 civilian, with the dominant theme being federal nuclear-security and nonproliferation analysis funding. The highest-conviction signal is that the $41,772,736 current obligation represents roughly 29% of the $146,156,020 base-plus-options ceiling, with $26,579,293 already outlayed, indicating funded and actively executing work. The primary watch item is the option-exercise and incremental-obligation trajectory against the ceiling, since the recipient is not a publicly traded equity and the investment read-through is limited to sector-level federal spending signals. Overall signal strength is neutral (3.0/10) with no direct equity exposure identified.

1 total filings
· daily

General Federal Contracts — October 22, 2026

Across 13 federal awards totaling $384,742,601 in obligations, the dataset is overwhelmingly civilian: only 1 award (CALIFORNIA INSTITUTE OF TECHNOLOGY's NASA GOMAP delivery order, $54,049,346, which is nonprofit and not publicly traded) is defense-related, and the defense-adjacent Aerospace Corporation NNSA delivery order ($41,772,736) is also a nonprofit FFRDC without public equity exposure. The dominant themes are civilian construction and facilities (USDA, Smithsonian, VA, DOE facilities) and professional/IT services across HHS, DHS, GSA and DOT. Every award is rated neutral (strength 2-3/10), and no contract clearly isolates a publicly traded recipient, so the highest-conviction takeaway is informational rather than directional: the largest-value awards accrue mainly to nonprofits, subsidiaries of foreign or private-equity parents, and private firms. The key watch item is outlay conversion, since several large obligations (Grunley $29.2M, CQ JV $22.9M, CDEEM $22.9M, Guidehouse $25.7M) show $0 disbursed, and the $401.7M ceiling on UNIVERSAL PROTECTION SERVICE's DHS border security order depends almost entirely on unexercised options.

13 total filings
· daily

All NASA Contracts — October 22, 2026

This digest covers a single NASA contract record dated October 22, 2026, with a total obligation of $54,049,346 and a base-plus-options value of $118,850,566. The award is entirely civilian (0 of 1 records defense-related), and the dominant theme is continued NASA investment in JPL-managed space science research through the Great Observatory Maturation Program (GOMAP). The recipient, California Institute of Technology, is a nonprofit, tax-exempt university and therefore has no direct public-equity exposure. The highest-conviction signal is the low contract risk profile, given a cost-plus-fixed-fee structure that shifts most overrun exposure to the government. The key watch item is the roughly $64.8M of ceiling value not yet obligated, which depends on future option exercise and incremental funding, and average signal strength across the stream is low at 2.0/10.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — October 22, 2026

Across the 21 filings in the USA S&P 500 Technology stream, the dominant theme is strong semiconductor-equipment and hardware momentum alongside a more mixed picture in legacy IT and software. Lam Research delivered record results with revenue of $8.22B (up 54% YoY per its 10-Q, 22% QoQ per its 8-K) and operating margin of 40.0%, but a 46% QoQ jump in tax expense trimmed net income growth relative to pre-tax growth. Texas Instruments posted revenue of $6.06B (up 28% YoY) and EPS up 77%, yet capital returns fell 11% YoY as buybacks dropped 61%, and its Q4 guidance band of $5.80B to $6.30B is wide. IBM showed steady top-line growth of about 5% with Software and Infrastructure leading, but IBM Z revenue fell 20% and Financing declined 4%, while $11.4B of acquisitions compressed free cash flow and cash fell about 32% YTD. Accenture filings are dominated by routine equity award vesting and tax withholding, with a cluster of Co-CEO and senior-officer share sales at roughly $240 to $250 that reads as normal liquidity rather than a clear conviction signal. Microsoft's proxy materials are governance-only, with 11 of 12 nominees independent and all four shareholder proposals recommended against. Overall, the stream reflects healthy earnings momentum in semiconductor capital equipment and semis, with cash deployment, tax normalization and legacy-segment erosion as the key watch items.

16 high priority 5 medium 21 total filings
· daily

Nasdaq 100 Stocks SEC Filings — October 22, 2026

Across the 12 filings, the NASDAQ-100 semiconductor and mega-cap platform names showed strong top-line momentum, while several media and advertising names showed contraction. Lam Research (revenue $8.22B, up 54% YoY, gross margin 52.3% vs 50.4%) and Texas Instruments (revenue $6.06B, up 28% YoY, net income up 78% YoY) led on growth and margin expansion, with Lam guiding December-quarter revenue to $8.60B. Meta and Comcast both showed headline earnings distorted by one-time items: Meta absorbed a $9.89B state attorneys general settlement charge (ex-charge diluted EPS would have been $7.40 vs reported $3.83) and Comcast's nine-month net income fell 48.7% against a prior-year $9.7B investment gain that did not recur. Tesla's flat revenue masked a 55.8% drop in operating income as R&D rose 69% to $2.76B, and its automotive regulatory credits fell 73%. Capital allocation diverged sharply: Meta repurchased no shares in nine months after $26.2B in the prior-year period while capex reached $83.1B, and Texas Instruments cut cash returns 11% YoY as buybacks fell 61%. Insider activity was limited to routine 10b5-1 sales at Apple and Starbucks and carried little signal. Overall, the cycle favors semiconductor equipment and analog/industrial silicon, while platform and media names are being hit by one-time charges, capex intensity and cost inflation.

7 high priority 5 medium 12 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — October 22, 2026

The 50 filings in this stream are dominated by routine passive Schedule 13G and 13G/A disclosures, most of which are sponsor, adviser, or bank holding-company reports on fund and ETF stakes with neutral sentiment and materiality of 2-4/10. The material activity is concentrated in a small set of genuine ownership events: EdgePoint's 17.68% Schedule 13D stake in Mattel with a board cooperation agreement (materiality 8/10), Gary Bowman's insider backing of the $43.00 take-private of Bowman Consulting, Glenbrook Capital's accelerating open-market accumulation toward 40% of SenesTech, and Everrise Holdings' 34.51% stake in ATA Creativity Global with stated intent to influence strategy. Several filings are explicitly mechanical, including Indaptus dilution-driven percentage declines, the NorthStrive over-allotment forfeiture, and Suncrete internal distributions, so they carry no real trading signal. The stream's enriched period-over-period financial data is largely absent because most filings are ownership-only reports, which limits quantitative margin or growth comparisons. Overall the signal is that activist and large-holder conviction is building around a few targets, while the institutional ETF-sponsor filings are background noise.

15 high priority 35 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — October 22, 2026

Five SEC filings dated October 22, 2026 were reviewed for the S&P 500 Financials stream. Four are in scope: Travelers Companies (three Form 4s), Citigroup (8-K board appointment), CME Group (Form 4), and AIG (13F-HR). The dominant theme is insider selling: Travelers executives sold roughly $8.4M of stock in aggregate, with the Chief Risk Officer and EVP Personal Insurance both monetizing positions near $393-398, while CME's director sold a small $121K block. The enriched data provided no period-over-period financial metrics, guidance, or capital allocation figures, so trend analysis is limited to insider and governance signals. AIG's 13F reveals a single 3.65M-share Rubrik position (~$175.6M per the filing, though the value field appears mis-scaled and should be verified). Citigroup's appointment of Jim Flanagan adds a former PwC COO/Vice Chairman with audit credentials to the board, a governance positive with no financial impact disclosed. Overall materiality is low; the most actionable item is the clustering of Travelers insider sales.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Energy Sector SEC Filings — October 22, 2026

Two S&P 500 Energy filings were published on 2026-10-22: Kinder Morgan's Q3 2026 8-K with substantive enriched results, and Valero's Q3 2026 8-K furnishing an earnings press release whose figures were not included in the provided content. Kinder Morgan delivered a strong quarter on headline metrics (net income attributable to KMI up 22% to $764 million, Adjusted EPS up 21% to $0.35, Adjusted EBITDA up 9% to $2.18 billion), with the expansion backlog growing to $14.4 billion, of which $13.2 billion is natural gas, supporting multi-year volume visibility. Performance was mixed underneath: Natural Gas Pipelines and Terminals grew, while crude and condensate volumes fell 11% YoY on lower Bakken flows and the Double H conversion to NGL service, and Products Pipelines earnings were absorbed by legal and environmental accruals classified as Certain Items. Leverage is a positive signal, with Net Debt-to-Adjusted EBITDA at 3.5x, the low end of the target range, and a year-end target of 3.6x versus a prior 3.8x budget, which points to balance-sheet headroom for the dividend (raised 2% YoY to $0.2975 per share) and project funding. Valero's filing carries no quantitative data and warrants a neutral read until the Exhibit 99.01 release is reviewed. Across the two names, the sector theme is gas-levered infrastructure strength offsetting pockets of crude-linked and litigation-related weakness.

2 medium 2 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — October 22, 2026

All three filings relate to Procter & Gamble (PG), so this digest is effectively a single-company read-through rather than a cross-company sector scan. Fiscal Q1 2027 (quarter ended September 30, 2026) delivered net sales of $23.3B, up 4.0% YoY, with organic growth also at 4.0% (2% volume, 1% mix), but earnings quality was weak: diluted EPS rose only 1% to $1.97, currency-neutral core EPS was flat, and net earnings attributable to P&G slipped 0.4%. Core gross margin contracted 150 bps on 140 bps of commodity cost inflation and 140 bps of reinvestment, partly offset by 120 bps of productivity savings. The balance sheet shifted toward short-term funding, with debt due within one year rising to $17.0B from $11.3B while cash rose to $15.4B from $9.9B, and interest expense grew 13.2%. Management raised all-in FY2027 sales growth guidance to 2-4% to reflect the Thorne acquisition while holding organic sales, EPS and cash return guidance, but flagged a ~$0.79/share headwind from commodities, interest, lower non-operating income and FX. The net read is mixed: top-line momentum is intact, but margin and FX pressure are absorbing the growth.

1 high priority 2 medium 3 total filings
· daily

S&P 500 Industrials Sector SEC Filings — October 22, 2026

Across the ten S&P 500 Industrials filings (Lockheed Martin, CSX, Honeywell, Union Pacific, Norfolk Southern and GE's 13F), the dominant theme is strong top-line momentum undermined by cost and cash-flow pressure. Revenue growth was broad: Lockheed sales rose 11.3% to $20.7B with a record $292.0B backlog, CSX revenue rose 12% to a record $4.02B, Union Pacific revenue rose 15.3% to $7.2B, and Norfolk Southern railway revenue rose 13.6% to $3.5B. However, margins and cash generation lagged. Union Pacific's fuel expense jumped 68.8% (costing roughly 140 bps of operating ratio), Norfolk Southern's adjusted operating ratio worsened 210 bps to 65.4% and eight of its 14 points of revenue growth came from fuel surcharges, and Lockheed's operating cash flow fell 8% with Aeronautics margin compressing to 9.0% from 9.4%. Honeywell's reported picture was distorted by a $6.6B deconsolidation gain and the Aerospace spin-off, with Q3 operating cash flow down 74% and an Industrial Automation segment down 23% on a reported basis. Rail carriers face a common fuel-cost headwind, and defense primes face a funding question on the F-35 Lot 20 advance contract. Capital return patterns diverged sharply: Lockheed and Union Pacific cut buybacks to near zero year-to-date, while dividends were steady.

5 high priority 5 medium 10 total filings
· daily

US Material Events SEC 8-K Filings — October 22, 2026

Across the 50 SEC filings dated 2026-10-22, the dominant themes are officer and governance transitions, financing and capital-structure actions, and a handful of material M&A and earnings events. The most market-moving items are Meta's Q3 2026 results (revenue +26% YoY but a $9.89B legal charge compressing operating margin to 20% from 40%), H.B. Fuller's $850M notes issuance tied to the AMS acquisition, and Select Water's $900M notes tied to the Pilot Water acquisition, both carrying special mandatory redemption triggers. Earnings-based period comparisons are mixed: Deckers' record Q2 EPS (+27% YoY) was flattered by ~$0.28 of IEEPA tariff refunds while comparable DTC sales fell 6.4%, Lindsay's Q4 rebounded (+5% revenue, +39% operating income) but full-year revenue fell 6% to $635.9M, and Ategrity's record-low 84.7% combined ratio coexisted with a 35.7% decline in net income on investment losses. Distress and liquidity pressure appear in several names (America's Car-Mart's new $5.0M senior secured term loans, Glucotrack's reverse split to meet Nasdaq minimum bid, Shuttle Pharmaceuticals' auditor dismissal with going-concern history, and Nano Mobile's going-concern opinion), while the Invesco fund-family personnel changes (ten-plus trusts with an identical Gallegos-to-Anello PFAO transition) represent a single administrative event rather than separate signals.

50 high priority 50 total filings
· daily

Insider Trading Pulse — October 22, 2026

The 50 filings for the 2026-10-22 Insider Trading Pulse digest are dominated by routine equity compensation and dividend-equivalent awards, with genuine open-market activity concentrated in a small set of names. Most transactions are mechanical: Erie Indemnity's executive Incentive Compensation Deferral Plan share credits at $245.94, Security Midwest Bancorp's uniform director grants of 1,334 common shares plus 2,669 options, and NorthStrive Acquisition Corp I's Class B share dispositions. Discretionary selling clusters in the financial and semiconductor/software names, including Bank7 Corp's EVP sale of 1,614 shares at $57.60, Credo's CTO selling 7,420 shares at about $173.55 under a 10b5-1 plan, and Intapp's President, Industries selling 40,284 shares at $45.26 (~$1.82M), also under a 10b5-1 plan. The most material single event is CHEMED's CEO option award of 36,693 options at $512.64 (~$18.8M). Because the filings carry no period-over-period, guidance, or capital-allocation fields, trend analysis is limited to the transaction data itself, and the signals below should be read as insider-behavior indicators rather than fundamental calls. Pre-planned 10b5-1 sales and tax withholdings should be weighted lower than discretionary open-market sales when assessing conviction.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — October 22, 2026

Across the 23 Dow Jones 30 filings (period 2026-10-22), the dominant theme is a split between strong top-line and cash-flow stories and weaker reported earnings quality. IBM (Q3 revenue +4.7% YoY to $17.1B, operating pre-tax margin +70 bps to 19.3%, but IBM Z -20% and Financing -4%) and Honeywell (organic +7% and adjusted EPS +34%, but reported EPS -20%, operating cash flow -74%, and Industrial Automation sales -23% reported) both show headline improvement masking underlying softness. Procter & Gamble delivered 4.0% sales growth but flat currency-neutral core EPS and a 150 bps core gross margin decline, while raising all-in FY2027 sales guidance to 2-4% on the Thorne acquisition. Honeywell's Q3 net income fell 64% YoY, and YTD results are dominated by a $6.6B deconsolidation gain and Aerospace Spin-Off accounting, so reported comparisons are not like-for-like. Insider activity is concentrated in Travelers (two EVP/CRO-level sales totaling roughly $8.4M, with sales by Klein and Olivo) and a single Apple SVP sale under a 10b5-1 plan, while Sherwin-Williams shows routine option grants across roughly 12 executives with no open-market buying. Capital allocation remains shareholder-friendly (IBM $1.69 quarterly dividend, P&G cash returns maintained), but IBM's $11.4B of acquisitions and P&G's shift to short-term debt ($17.0B due within one year, up from $11.3B) warrant balance-sheet monitoring. Governance filings for Microsoft (11 of 12 independent nominees, annual meeting December 8, 2026) are routine.

17 high priority 6 medium 23 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 22, 2026

This distress stream covers four 8-K filings dated around October 2026, all in scope for bankruptcy, going-concern, or delisting events. Leslie's is the most severe case: a pre-arranged Chapter 11 with an RSA, a disclosure statement and plan filed October 20, 2026, Nasdaq delisting, and an explicit warning that equity holders may be significantly impaired. Atlantic American (AAME) faces a Nasdaq delisting determination for missed 10-K/10-Q filings, with a Hearings Panel request due October 23, 2026. SenesTech (SNES) has a sub-$1 bid-price deficiency with a compliance deadline of April 19, 2027, a lower-urgency but still negative signal. Alaunos Therapeutics is the one filing showing a potential reversal: it claims to have regained the $2.5M stockholders' equity requirement after a merger and a roughly $350M private placement, though the outcome hinges on Nasdaq Staff confirmation before the November 10, 2026 Panel hearing. The filings provide no period-over-period financial figures, insider transactions, or capital allocation data, so quantitative trend comparisons are not possible; the analysis rests on listing-status events and restructuring milestones.

4 high priority 4 total filings
· daily

Global High-Priority Regulatory Events — October 22, 2026

The 50-filing stream is dominated by distressed and restructuring events (Leslie's Chapter 11, Nasdaq delisting notices for SPACs and listed issuers, Indian CIRP/insolvency meetings) alongside a steady flow of M&A and open offers, mostly in India. Period-over-period data is mixed: Jindal Stainless standalone revenue rose 4.9% YoY and profit 22.0% YoY, but H1 PBT grew only ~3.8% and power/fuel costs rose ~25%, signalling margin pressure; Shakti Pumps' subsidiary turnover jumped on a low base; Oseaspre's losses widened YoY; ZLRAI turnover grew ~29%. The most market-moving items are the Leslie's bankruptcy (10/10 materiality, equity likely impaired), the Alaunos equity-compliance situation dependent on a Nasdaq Staff confirmation, and Globa Terra and Atlantic American facing imminent delisting proceedings. Positive strategic moves include the Data I/O V-TEK acquisition (~doubling revenue) and the Cadeler redomiciliation exchange offer, which remains short of its minimum condition. Several SPACs (Charlton Aria, Range Capital, DT Cloud Star, Texas Ventures III) are routinely extending deadlines via sponsor contributions, a sign of stalled combinations. Note that the 'Period' is a single day and several filings contain no quantitative data, which limits the depth of comparative analysis.

50 high priority 50 total filings